We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHLT
1926
DELISTED
Performant Healthcare Inc
PHLT
$6K ﹤0.01%
2,726
+950
+53% +$2.14K
BCPC
1927
Balchem Corp
BCPC
$5.58B
$6K ﹤0.01%
79
-83
-51% -$6.62K
ERF
1928
DELISTED
Enerplus Corporation
ERF
$6K ﹤0.01%
737
-2,104
-74% -$16.6K
AMJ
1929
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$6K ﹤0.01%
200
-85
-30% -$2.61K
CMLS
1930
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$6K ﹤0.01%
+14,270
New +$5.45K
MARK
1931
DELISTED
Remark Holdings, Inc.
MARK
$6K ﹤0.01%
232
+201
+648% +$5.75K
CCF
1932
DELISTED
Chase Corporation
CCF
$6K ﹤0.01%
+57
New +$5.94K
ATTO
1933
DELISTED
Atento S.A.
ATTO
$6K ﹤0.01%
108
-322
-75% -$16K
MLVF
1934
DELISTED
Malvern Bancorp, Inc.
MLVF
$6K ﹤0.01%
+246
New +$5.47K
UMPQ
1935
DELISTED
Umpqua Holdings Corp
UMPQ
$6K ﹤0.01%
300
+1
+0.3% +$18
PFBI
1936
DELISTED
Premier Financial Bancorp
PFBI
$6K ﹤0.01%
+375
New +$6.21K
GLOG
1937
DELISTED
GASLOG LTD
GLOG
$6K ﹤0.01%
+419
New +$5.9K
OCSI
1938
DELISTED
Oaktree Strategic Income Corporation
OCSI
$6K ﹤0.01%
+714
New +$5.64K
NGHC
1939
DELISTED
National General Holdings Corp
NGHC
$6K ﹤0.01%
308
+265
+616% +$5.85K
DNR
1940
DELISTED
Denbury Resources, Inc.
DNR
$6K ﹤0.01%
+3,700
New +$6.92K
PTLA
1941
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$6K ﹤0.01%
103
+3
+3% +$120
LBY
1942
DELISTED
Libbey, Inc.
LBY
$6K ﹤0.01%
+798
New +$7.76K
FWP
1943
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$6K ﹤0.01%
43
NCI
1944
DELISTED
Navigant Consulting, Inc.
NCI
$6K ﹤0.01%
+300
New +$6.33K
DYNC
1945
DELISTED
Vistra Energy Corp.
DYNC
$6K ﹤0.01%
+100
New +$5.79K
ALOG
1946
DELISTED
Analogic Corp
ALOG
$6K ﹤0.01%
+83
New +$5.95K
EXAC
1947
DELISTED
Exactech Inc
EXAC
$6K ﹤0.01%
200
-385
-66% -$11.3K
RICE
1948
DELISTED
Rice Energy Inc.
RICE
$6K ﹤0.01%
225
-712
-76% -$15.8K
CDI
1949
DELISTED
CDI Corp.
CDI
$6K ﹤0.01%
998
-2,053
-67% -$14.1K
IMED
1950
DELISTED
PureFunds ETFx HealthTech ETF
IMED
$6K ﹤0.01%
+196
New +$5.55K

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.